Prestige Consumer Healthcare Inc. buy StockNews.com
Start price
17.05.25
/
50%
€77.50
Target price
17.05.26
-
Performance (%)
-30.97%
Price
25.09.25
€53.50
Summary
This prediction is currently active. The BUY prediction by StockNews_com for Prestige Consumer Healthcare Inc. is performing very badly with a performance of -30.97%. This prediction currently runs until 17.05.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Prestige Consumer Healthcare Inc. | -0.926% | -0.926% |
| iShares Core DAX® | 0.378% | -1.910% |
| iShares Nasdaq 100 | -0.117% | 3.610% |
| iShares Nikkei 225® | -0.806% | 4.615% |
| iShares S&P 500 | 0.059% | 2.263% |
Comments by StockNews_com for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PBH provided by MarketBeat
Stopped prediction by StockNews_com for Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€63.00
10.02.24
10.02.24
-
10.02.25
10.02.25
30.16%
11.02.25
11.02.25
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€54.50
16.12.23
16.12.23
-
16.12.24
16.12.24
42.20%
17.12.24
17.12.24
Prestige Consumer Healthcare Inc.
Start price
Target price
Perf. (%)
€52.50
24.06.23
24.06.23
-
24.06.24
24.06.24
20.95%
25.06.24
25.06.24